Aptus Capital Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.74M | Buy |
11,702
+3,031
| +35% | +$1.23M | 0.04% | 294 |
|
|
2025
Q1 | $4.31M | Sell |
8,671
-34,309
| -80% | -$17.1M | 0.04% | 295 |
|
|
2024
Q4 | $22.4M | Buy |
42,980
+5,215
| +14% | +$2.71M | 0.23% | 86 |
|
|
2024
Q3 | $23.4M | Buy |
37,765
+5,996
| +19% | +$3.71M | 0.35% | 70 |
|
|
2024
Q2 | $17.6M | Buy |
31,769
+6,695
| +27% | +$3.7M | 0.31% | 72 |
|
|
2024
Q1 | $14.6M | Buy |
25,074
+2,607
| +12% | +$1.52M | 0.27% | 73 |
|
|
2023
Q4 | $11.9M | Buy |
22,467
+34
| +0.2% | +$18K | 0.33% | 72 |
|
|
2023
Q3 | $11.4M | Sell |
22,433
-988
| -4% | -$500K | 0.31% | 73 |
|
|
2023
Q2 | $12.2M | Sell |
23,421
-1,234
| -5% | -$644K | 0.29% | 65 |
|
|
2023
Q1 | $14.2M | Buy |
24,655
+1,709
| +7% | +$985K | 0.38% | 51 |
|
|
2022
Q4 | $12.6M | Sell |
22,946
-1,587
| -6% | -$874K | 0.39% | 51 |
|
|
2022
Q3 | $12.4M | Buy |
24,533
+1,624
| +7% | +$824K | 0.3% | 45 |
|
|
2022
Q2 | $12.4M | Sell |
22,909
-16
| -0.1% | -$8.69K | 0.32% | 37 |
|
|
2022
Q1 | $13.5M | Buy |
22,925
+3,033
| +15% | +$1.79M | 0.34% | 28 |
|
|
2021
Q4 | $13.3M | Buy |
19,892
+3,009
| +18% | +$2.01M | 0.4% | 27 |
|
|
2021
Q3 | $9.65M | Buy |
16,883
+4,049
| +32% | +$2.31M | 0.25% | 32 |
|
|
2021
Q2 | $6.47M | Buy |
12,834
+6,117
| +91% | +$3.09M | 0.19% | 45 |
|
|
2021
Q1 | $3.07M | Buy |
6,717
+155
| +2% | +$70.7K | 0.11% | 79 |
|
|
2020
Q4 | $3.06M | Buy |
6,562
+948
| +17% | +$441K | 0.14% | 76 |
|
|
2020
Q3 | $2.48M | Buy |
5,614
+48
| +0.9% | +$21.2K | 0.13% | 81 |
|
|
2020
Q2 | $2.02M | Sell |
5,566
-888
| -14% | -$322K | 0.13% | 89 |
|
|
2020
Q1 | $1.83M | Buy |
+6,454
| New | +$1.83M | 0.16% | 96 |
|